United States· US:73515-123_d584b098-e98a-4453-aa48-9d79a470036c
CYCLOSET
A bromocriptine product containing bromocriptine mesylate, registered in United States by Avvisto Therapeutics LLC. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bromocriptine is registered in 8 of 19 countries.
Countries holding a registration under ATC N04BC01 (bromocriptine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Bromocriptine · ATC N04BC01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bromocriptine costs, country by country.
Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.
- United States: $32.93 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bromocriptine · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- US United States$32.93 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BROMOCRIPTINE MESYLATE
- Manufacturer
- Avvisto Therapeutics LLC
- Country
- United States (US)
- ATC code
- N04BC01
- ATC class
- Bromocriptine
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11735151232121 TABLET in 1 BOTTLE (73515-123-21)
- ndc117351512330200 TABLET in 1 BOTTLE (73515-123-30)
- ndc1173515-123-21
- ndc1173515-123-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for bromocriptine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromocriptine · interactions on record
92 records
- 3 severe
- 87 moderate
- 2 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- LansoprazoleA02BC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 10mg capsulesDowelhurst Ltd
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- FinlandParlodelMeda Oy
- SwedenParlodel 2,5 mg TablettOrifarm AB
- NorwayParlodelMeda
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
- FrancePARLODEL 10 mg, géluleEXELTIS SANTE
- SwitzerlandParlodel, TablettenSandoz Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/172c6244-7c5c-4e3f-abb4-1504df8b96d1 GET /v1/drugs/172c6244-7c5c-4e3f-abb4-1504df8b96d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".8",
"substance": "BROMOCRIPTINE MESYLATE",
"productndc": "73515-123",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA020866",
"marketing_category": "NDA"
}See everything about bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.